Clinical trials recruiting for Heterozygous Familial Hypercholesterolemia (HeFH)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CTX310 | 1 |
| Enlicitide Decanoate | 1 |
| SYH2053 injection | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 2 |
| Delaware | 1 |
| District of Columbia | 1 |
| Georgia | 1 |
| Massachusetts | 1 |
| New York | 1 |
| North Carolina | 1 |
| Ohio | 1 |
| Oregon | 1 |
| West Virginia | 1 |
| Wisconsin | 1 |
Top cities
Self-screener
Recruiting trials
- "Detection and Follow-up of Coronary Lesions in HeFH (DESTINY-FH Study)"
- A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
- A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
- The ORIGIN-FH Study
Related conditions
Trials recruiting for Heterozygous Familial Hypercholesterolemia (HeFH) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Heterozygous Familial Hypercholesterolemia (HeFH) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.